- Country: Russia
- Summary: Supply of a Medicinal Product for Medical Use Sildenafil to Provide Citizens Included in the List of Life-Threatening and Chronic Progressive Rare...
- RUT Ref No: 132666944
- Deadline: 14 Jan 2026
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: 214496.10
- Notice Type: Tender
- Document Ref. No.:Login to see details
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details.
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINSupply of a Medicinal Product for Medical Use Sildenafil to Provide Citizens Included in the List of Life-Threatening and Chronic Progressive Rare... - Russia Tender
The STATE PUBLIC INSTITUTION "CENTER FOR PUBLIC PROCUREMENT OF THE SAKHALIN REGION", a Government sector organization in Russia, has announced a new tender for Supply of a Medicinal Product for Medical Use Sildenafil to Provide Citizens Included in the List of Life-Threatening and Chronic Progressive Rare.... This tender is published on RussiaTenders under RUT Ref No: 132666944 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2026-01-14.
The estimated tender value is 214496.10, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
